Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

OIG Finds General Health IT Security Controls Lacking

Executive Summary

Although strong privacy and security controls are essential to the success of electronic health records and, more broadly, health information technology, a recent HHS Office of Inspector report reveals a lack of general security controls over health IT systems.

You may also be interested in...



Privacy Laws Remain Hurdle To Utilizing Personalized Medicine Through HIT

Privacy laws need to be updated to get the most out of personalized medicine when channeled through health information technology, including the ability to analyze personal information for research purposes and the provision of data to patients to better inform decision about their own care.

Privacy, Security Issues Key To Building Trust In HIT - eHealth Initiative

Knowledge and transparency of privacy and security policies will be key in gaining consumer trust in health information technology and health information exchanges, according to a new report on health IT released by the eHealth Initiative

FDA 2015 Budget Increase Proposal Leans On Food Safety User Fees

Food safety programs would get the largest increase in the White House’s proposed fiscal 2015 FDA budget, and increases in user fee programs are proposed as key drivers for the boost. The agency’s overall budget would grow $335 million to $4.7 billion in the proposal.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS053424

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel